Literature DB >> 34859286

Successful diagnosis of veno-occlusive disease caused by inotuzumab ozogamicin through minimal-invasive angiography: a case report.

Michiaki Sato1, Megumi Yasunaga1, Masami Ohzu1, Kazuhiro Toyama1, Kumi Nakazaki1, Fumio Nakahara1, Takatoshi Kubo2, Naoki Okura3, Osamu Abe2, Mineo Kurokawa4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34859286     DOI： 10.1007/s00277-021-04713-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  9 in total

1.  Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic Leukemia.

Authors:  A Delannoy; C Sebban; P Cony-Makhoul; B Cazin; C Cordonnier; R Bouabdallah; J Y Cahn; F Dreyfus; A Sadoun; J P Vernant; C Gay; A Broustet; J L Michaux; D Fière
Journal:  Leukemia       Date:  1997-09       Impact factor: 11.528

2.  Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.

Authors:  Mutsumi Nishida; Kaoru Kahata; Eiko Hayase; Akio Shigematsu; Megumi Sato; Yusuke Kudo; Satomi Omotehara; Takahito Iwai; Junichi Sugita; Hitoshi Shibuya; Chikara Shimizu; Takanori Teshima
Journal:  Biol Blood Marrow Transplant       Date:  2018-05-24       Impact factor: 5.742

Review 3.  Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.

Authors:  Selim Corbacioglu; Elias J Jabbour; Mohamad Mohty
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-22       Impact factor: 5.742

4.  Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study.

Authors:  Hagop M Kantarjian; Daniel J DeAngelo; Anjali S Advani; Matthias Stelljes; Partow Kebriaei; Ryan D Cassaday; Akil A Merchant; Naohito Fujishima; Toshiki Uchida; Maria Calbacho; Anna A Ejduk; Susan M O'Brien; Elias J Jabbour; Hui Zhang; Barbara J Sleight; Erik R Vandendries; David I Marks
Journal:  Lancet Haematol       Date:  2017-07-04       Impact factor: 18.959

5.  Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention.

Authors:  S Corbacioglu; J Greil; C Peters; N Wulffraat; H J Laws; D Dilloo; B Straham; U Gross-Wieltsch; K W Sykora; A Ridolfi-Lüthy; O Basu; B Gruhn; T Güngör; W Mihatsch; A S Schulz; B Strahm
Journal:  Bone Marrow Transplant       Date:  2004-01       Impact factor: 5.483

6.  BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.

Authors:  Fiona L Dignan; Robert F Wynn; Nedim Hadzic; John Karani; Alberto Quaglia; Antonio Pagliuca; Paul Veys; Michael N Potter
Journal:  Br J Haematol       Date:  2013-09-17       Impact factor: 6.998

7.  Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.

Authors:  Hagop M Kantarjian; Daniel J DeAngelo; Matthias Stelljes; Giovanni Martinelli; Michaela Liedtke; Wendy Stock; Nicola Gökbuget; Susan O'Brien; Kongming Wang; Tao Wang; M Luisa Paccagnella; Barbara Sleight; Erik Vandendries; Anjali S Advani
Journal:  N Engl J Med       Date:  2016-06-12       Impact factor: 91.245

8.  Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.

Authors:  Paul G Richardson; Marcie L Riches; Nancy A Kernan; Joel A Brochstein; Shin Mineishi; Amanda M Termuhlen; Sally Arai; Stephan A Grupp; Eva C Guinan; Paul L Martin; Gideon Steinbach; Amrita Krishnan; Eneida R Nemecek; Sergio Giralt; Tulio Rodriguez; Reggie Duerst; John Doyle; Joseph H Antin; Angela Smith; Leslie Lehmann; Richard Champlin; Alfred Gillio; Rajinder Bajwa; Ralph B D'Agostino; Joseph Massaro; Diane Warren; Maja Miloslavsky; Robin L Hume; Massimo Iacobelli; Bijan Nejadnik; Alison L Hannah; Robert J Soiffer
Journal:  Blood       Date:  2016-01-29       Impact factor: 22.113

9.  Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.

Authors:  M Mohty; F Malard; M Abecassis; E Aerts; A S Alaskar; M Aljurf; M Arat; P Bader; F Baron; A Bazarbachi; D Blaise; F Ciceri; S Corbacioglu; J-H Dalle; F Dignan; T Fukuda; A Huynh; T Masszi; M Michallet; A Nagler; M NiChonghaile; S Okamoto; A Pagliuca; C Peters; F B Petersen; P G Richardson; T Ruutu; B N Savani; E Wallhult; I Yakoub-Agha; R F Duarte; E Carreras
Journal:  Bone Marrow Transplant       Date:  2016-05-16       Impact factor: 5.483
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.